SHR-4712
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
January 29, 2026
A Phase I Study of SHR-4712 in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=15 | Active, not recruiting | Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd | Recruiting ➔ Active, not recruiting | N=126 ➔ 15
Enrollment change • Enrollment closed • First-in-human • Solid Tumor
June 13, 2025
A Phase I Study of SHR-4712 in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=126 | Recruiting | Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd | Not yet recruiting ➔ Recruiting
Enrollment open • Solid Tumor
May 28, 2025
A Phase I Study of SHR-4712 in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=126 | Not yet recruiting | Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd
New P1 trial • Solid Tumor
1 to 3
Of
3
Go to page
1